PharmaOnco™ CMV pp65 (495-503), HLA-A*0201

CAT#: ITS-0622-YT220
Product Type: Peptide
Species: Human
Product Overview
A peptide that binds to HLA-A*0201 and is derived from CMV, the sequence of this peptide is NLVPMVATV.
Applications
Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion, Cellular immune response
Size
1mg
Species
Human
Number of Peptides
1
Source
Human cytomegalovirus (HCMV)
Recommended Use
The peptide is recommended to use for in-vitro T cell expansion, stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Area of Interest
Immunology
Limitation
Restrictions for research use only. Intended for use by laboratory professionals.
Shelf Life
Stable as supplied until expiry date on label.
Storage
Store at -20°C
Molecular Weight
943.2
Format
Lyophilized powder
Formulation
Lyophilized as trifluoroacetate salts
For Research Use Only | Not For Clinical Use
Online Inquiry